Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 26

Sort by

Sort Order Select

Journal Articles

Single-cell analysis of the multiple myeloma microenvironment after gamma-secretase inhibition and CAR T-cell therapy

David G Coffey, Pinar Ataca Atilla, Erden Atilla, Ola Landgren, Andrew J Cowan, Sylvain Simon, Margot Pont, Melissa L. Comstock, Geoffrey R Hill, Stanley R. Riddell, Damian J Green

Blood blood.2024025231.

https://doi.org/10.1182/blood.2024025231

Published: 2024

Includes: Supplemental data

Journal Articles

Trogocytosis May Attenuate the Efficacy of Anti-BCMA CAR T Cells Administered in Combination with γ-Secretase Inhibitor

Pinar Ataca Atilla, Sylvain Simon, Erden Atilla, Melissa L Comstock, Andrew J. Cowan, Geoffrey R Hill, Stanley R. Riddell, Damian J Green

Blood (2023) 142 (Supplement 1): 2083.

https://doi.org/10.1182/blood-2023-187132

Published: 2023

Journal Articles

Comparison of Two Alkylating Agents Among Refractory Multiple Myeloma: Published and Our Retrospective Bendamustine Combination Experience with Melflufen As Single Agent

Ekin Kircali, MD, Guldane Cengiz, MD, Sevgi Çolak, MD, Mehmet Gunduz, MD, Pinar Ataca Atilla, MD, Erden Atilla, MD, Mehmet Özen, MD, Muhit Ozcan, Meral Beksac, MD

Blood (2020) 136 (Supplement 1): 13–14.

https://doi.org/10.1182/blood-2020-137486

Published: 2020

Journal Articles

Combinatorial Antigen Targeting Strategy for Acute Myeloid Leukemia

Pinar Ataca Atilla, MD, Mary K McKenna, PhD, Norihiro Watanabe, PhD, Maksim Mamonkin, PhD, Malcolm K. Brenner, MD PhD, Erden Atilla, MD

Blood (2020) 136 (Supplement 1): 22–23.

https://doi.org/10.1182/blood-2020-141540

Published: 2020

Journal Articles

Enhancing the Effect of CLL-1 CAR T Cells with Interleukin-15 for Treatment of Acute Myeloid Leukemia

Pinar Ataca Atilla, MD, Haruko Tashiro, MD PhD, Mary Kathryn McKenna, PhD, Madhuwanti Srinivasan, Brian Wesley Simons, Alexandra McLean Stevens, MD PhD, Michele Redell, MD PhD, Maksim Mamonkin, PhD, Malcolm K. Brenner, MD PhD, Erden Atilla, MD

Blood (2019) 134 (Supplement_1): 3912.

https://doi.org/10.1182/blood-2019-127953

Published: 2019

Journal Articles

Impact of ABO Mismatch on Outcomes of Allogeneic Hematopoietic Stem Cell Recipients: 30 Years of Experience with 1016 Patients

Erden Atilla, MD, Pervin Topcuoglu, MD, Erman Akkus, MD, Pinar Ataca Atilla, MD, Sinem Civriz Bozdag, MD, Meltem Kurt Yuksel, MD, Taner Demirer, MD, Muhit Özcan, Meral Beksac, MD, Osman Ilhan, MD, Hamdi Akan, MD, Onder Arslan, MD, Gunhan Gurman, MD, Selami Kocak Toprak, MD

Blood (2018) 132 (Supplement 1): 3472.

https://doi.org/10.1182/blood-2018-99-118314

Published: 2018

Journal Articles

Evaluation of Elderly Patients with Hematological Malignancies By Two Different Geriatric Risk Scoring Systems: G8 and Flemish Version of the Triage Risk Screening Tool (fTRST)

Erden Atilla, MD, Merih Yalciner, MD, Ozlem Kilic, RN, Nurhayat Muftuoglu, RN, Pinar Ataca Atilla, MD, Sinem Civriz Bozdag, MD, Selami Kocak Toprak, MD, Meltem Kurt Yuksel, MD, Muhit Özcan, Gunhan Gurman, MD, Osman Ilhan, MD

Blood (2018) 132 (Supplement 1): 5902.

https://doi.org/10.1182/blood-2018-99-118275

Published: 2018

Journal Articles

Dilemma-High Response Rates Vs High Toxicity: Autologous Stem Cell Transplantation for Lymphoma

Erden Atilla, MD, Selami Kocak Toprak, MD, Sinem Civriz Bozdag, MD, Meltem Yuksel, MD, Pervin Topcuoglu, MD, Hamdi Akan, MD, Onder Arslan, MD, Taner Demirer, MD, Meral Beksac, MD, Osman Ilhan, MD, Muhit Ozcan, MD, Gunhan Gurman, MD

Blood (2017) 130 (Supplement 1): 5528.

https://doi.org/10.1182/blood.V130.Suppl_1.5528.5528

Published: 2017

Journal Articles

Comparison of Reduced Intensity Conditioning (RIC) Regimen and Myeloablative Conditioning (MAC) Regimen in Allogeneic Hematopoietic Stem Cell Transplantation (Allo-HSCT) for Adult Patients with Acute Leukemia

Gunhan Gurman, MD, Gozde Aydemir Guloksuz, MD, Erden Atilla, MD, Pinar Ataca Atilla, MD, Sinem Civriz Bozdag, MD, Meltem Kurt Yuksel, MD, Selami Kocak Toprak, MD, Pervin Topcuoglu, MD, Onder Arslan, MD, Muhit Ozcan, MD, Taner Demirer, MD, Osman Ilhan, MD, Hamdi Akan, MD, Meral Beksac, MD

Blood (2016) 128 (22): 5757.

https://doi.org/10.1182/blood.V128.22.5757.5757

Published: 2016

Journal Articles

Does Hypogammaglobulinemia at Diagosis Effects Survival and Infection Risk in Chronic Lymphocytic Leukemia (CLL)?

Erden Atilla, MD, Pinar Ataca Atilla, MD, Sinem Civriz Bozdag, MD, Selami Kocak Toprak, MD, Pervin Topcuoglu, MD, Osman Ilhan, MD, Muhit Ozcan, MD, Onder Arslan, MD

Blood (2016) 128 (22): 5577.

https://doi.org/10.1182/blood.V128.22.5577.5577

Published: 2016

Journal Articles

Therapeutic Plasma Exchange for Thrombotic Microangiopathy

Osman Ilhan, MD, Erden Atilla, MD, Pinar Ataca Atilla, MD, Sinem Civriz Bozdag, MD, Meltem Kurt Yuksel, MD, Selami Kocak Toprak, MD, Pervin Topcuoglu, MD, Hamdi Akan, MD, Taner Demirer, MD, Meral Beksac, MD, Onder Arslan, MD, Muhit Ozcan, MD, Gunhan Gurman, MD

Blood (2016) 128 (22): 4939.

https://doi.org/10.1182/blood.V128.22.4939.4939

Published: 2016

Journal Articles

Does Donor Epstein-Barr Virus (EBV) Seropositivity Affect Recipient's Risk of Graft Versus Host Disease (GVHD) in Allogeneic Hematopoietic Stem Cell Transplantation (Allo-HSCT)?

Erden Atilla, MD, Esmanur Kaplan, MD, Pinar Ataca Atilla, MD, Selami Kocak Toprak, MD, Pervin Topcuoglu, MD, Hamdi Akan, MD

Blood (2016) 128 (22): 5766.

https://doi.org/10.1182/blood.V128.22.5766.5766

Published: 2016

Journal Articles

Positive Impact of Chronic Graft-Versus Host Disease on Survival in 928 Allogeneic Hematopoietic Stem Cell Transplant Recipients

Gunhan Gurman, MD, Pinar Ataca, MD, Erden Atilla, MD, Sinem Civriz Bozdag, MD, Selami Kocak Toprak, MD, Meltem Kurt Yuksel, MD, Taner Demirer, MD, Hamdi Akan, MD, Onder Arslan, MD, Pervin Topcuoglu, MD, Meral Beksac, MD, Osman Ilhan, Muhit Ozcan, MD

Blood (2015) 126 (23): 1952.

https://doi.org/10.1182/blood.V126.23.1952.1952

Published: 2015

Journal Articles

Extracorporeal Photopheresis for the Treatment of Mycosis Fungoides

Erden Atilla, MD, Pinar Ataca, MD, Sinem Civriz Bozdag, MD, Selami Kocak Toprak, MD, Meltem Kurt Yuksel, MD, Bengu Nisa Akay, MD, Hatice Sanli, MD, Pervin Topcuoglu, MD, Muhit Ozcan, MD, Gunhan Gurman, MD, Osman Ilhan

Blood (2015) 126 (23): 5062.

https://doi.org/10.1182/blood.V126.23.5062.5062

Published: 2015

Journal Articles

Comparison of Two Different Doses of Corticosteroid Premedication for Antithymocyte Globulin in Allogeneic Hematopoietic Stem Cell Transplantation

Mustafa Merter, MD, Erden Atilla, MD, Ugur Sahin, MD, Sinem Civriz Bozdag, MD, Meltem Kurt Yuksel, MD, Pervin Topcuoglu, MD, Onder Arslan, MD, Muhit Ozcan, MD, Taner Demirer, MD, Gunhan Gurman, MD, Osman Ilhan, Hamdi Akan, MD, Meral Beksac, MD, Selami Kocak Toprak, MD

Blood (2015) 126 (23): 5456.

https://doi.org/10.1182/blood.V126.23.5456.5456

Published: 2015

Journal Articles

Upper and Lower Respiratory Tract Infections By Respiratory Viruses in Adult Recipients of Allogeneic Hematopoietic Stem Cell Transplantation (Allo-HSCT)

Erden Atilla, MD, Pinar Ataca, MD, Didem Sahin, MD, Pervin Topcuoglu, MD, Istar Dolapci, MD, Alper Tekeli, MD, Selami Kocak Toprak, MD, Sinem Civriz Bozdag, MD, Meltem Kurt Yuksel, MD, Muhit Ozcan, MD, Gunhan Gurman, MD

Blood (2015) 126 (23): 5479.

https://doi.org/10.1182/blood.V126.23.5479.5479

Published: 2015

Journal Articles

Is Initial CD3+ T Cell Dose in Donor Lymphocyte Infusion for Relapsed Hematological Malignancies a Prognostic Determinant?

Erden Atilla, MD, Pinar Ataca, MD, Selami Kocak Toprak, MD, Meltem Kurt Yuksel, MD, Pervin Topcuoglu, MD, Onder Arslan, MD, Muhit Ozcan, MD, Taner Demirer, MD, Osman Ilhan, Meral Beksac, MD, Hamdi Akan, MD, Gunhan Gurman, MD, Sinem Civriz Bozdag, MD

Blood (2015) 126 (23): 5483.

https://doi.org/10.1182/blood.V126.23.5483.5483

Published: 2015

Journal Articles

Seroprevalence for Toxoplasma Gondii in Allogeneic Hematopoietic Stem Cell Transplantation Recipients

Erden Atilla, MD, Pinar Ataca, MD, Sevinc Balli, MD, Baris Isikoglu, MD, Pervin Topcuoglu, MD, Muhit Ozcan, MD, Hamdi Akan, MD

Blood (2015) 126 (23): 5459.

https://doi.org/10.1182/blood.V126.23.5459.5459

Published: 2015

Journal Articles

Hepatitis B (HBV) Reactivation Rate and Fate Among Multiple Myeloma Patients Receiving Lenalidomide Containing Regimens: A Single Center Experience

Pinar Ataca, MD, Erden Atilla, MD, Ekin Kircali, MD, Ramazan Idilman, MD, Meral Beksac, MD

Blood (2015) 126 (23): 5377.

https://doi.org/10.1182/blood.V126.23.5377.5377

Published: 2015

Journal Articles

Is the Chronic Myeloproliferative Disease Prognosis Really Different in Geriatric Patients?

Osman Ilhan, MD, Pinar Ataca, MD, Erden Atilla, MD, Selami Kocak Toprak, MD, Gulsah Kaygusuz, MD, Isinsu Kuzu, MD, Sinem Civriz Bozdag, MD, Pervin Topcuoglu, MD, Onder Arslan, MD, Muhit Ozcan, MD, Meral Beksac, MD, Taner Demirer, MD, Hamdi Akan, MD, Nahide Konuk, MD, Gunhan Gurman, MD

Blood (2014) 124 (21): 5555.

https://doi.org/10.1182/blood.V124.21.5555.5555

Published: 2014

NARROW

Single-cell analysis of the multiple myeloma microenvironment after gamma-secretase inhibition and CAR T-cell therapy

Trogocytosis May Attenuate the Efficacy of Anti-BCMA CAR T Cells Administered in Combination with γ-Secretase Inhibitor

Comparison of Two Alkylating Agents Among Refractory Multiple Myeloma: Published and Our Retrospective Bendamustine Combination Experience with Melflufen As Single Agent

Combinatorial Antigen Targeting Strategy for Acute Myeloid Leukemia

Enhancing the Effect of CLL-1 CAR T Cells with Interleukin-15 for Treatment of Acute Myeloid Leukemia

Impact of ABO Mismatch on Outcomes of Allogeneic Hematopoietic Stem Cell Recipients: 30 Years of Experience with 1016 Patients

Evaluation of Elderly Patients with Hematological Malignancies By Two Different Geriatric Risk Scoring Systems: G8 and Flemish Version of the Triage Risk Screening Tool (fTRST)

Dilemma-High Response Rates Vs High Toxicity: Autologous Stem Cell Transplantation for Lymphoma

Comparison of Reduced Intensity Conditioning (RIC) Regimen and Myeloablative Conditioning (MAC) Regimen in Allogeneic Hematopoietic Stem Cell Transplantation (Allo-HSCT) for Adult Patients with Acute Leukemia

Does Hypogammaglobulinemia at Diagosis Effects Survival and Infection Risk in Chronic Lymphocytic Leukemia (CLL)?

Therapeutic Plasma Exchange for Thrombotic Microangiopathy

Does Donor Epstein-Barr Virus (EBV) Seropositivity Affect Recipient's Risk of Graft Versus Host Disease (GVHD) in Allogeneic Hematopoietic Stem Cell Transplantation (Allo-HSCT)?

Positive Impact of Chronic Graft-Versus Host Disease on Survival in 928 Allogeneic Hematopoietic Stem Cell Transplant Recipients

Extracorporeal Photopheresis for the Treatment of Mycosis Fungoides

Comparison of Two Different Doses of Corticosteroid Premedication for Antithymocyte Globulin in Allogeneic Hematopoietic Stem Cell Transplantation

Upper and Lower Respiratory Tract Infections By Respiratory Viruses in Adult Recipients of Allogeneic Hematopoietic Stem Cell Transplantation (Allo-HSCT)

Is Initial CD3+ T Cell Dose in Donor Lymphocyte Infusion for Relapsed Hematological Malignancies a Prognostic Determinant?

Seroprevalence for Toxoplasma Gondii in Allogeneic Hematopoietic Stem Cell Transplantation Recipients

Hepatitis B (HBV) Reactivation Rate and Fate Among Multiple Myeloma Patients Receiving Lenalidomide Containing Regimens: A Single Center Experience

Is the Chronic Myeloproliferative Disease Prognosis Really Different in Geriatric Patients?

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only